Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits

Alpharadin® in the treatment of skeletal metastasis secondary to metastatic prostate cancer: An educational exhibit

Eric Duong, Michael Orquiza, Gauri Khorjekar and Douglas Van Nostrand
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1308;
Eric Duong
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Orquiza
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gauri Khorjekar
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Van Nostrand
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1308

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Eric Duong1,
  2. Michael Orquiza1,
  3. Gauri Khorjekar1 and
  4. Douglas Van Nostrand1
  1. 1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014200
Dec 2014100
Jan 2015200
Feb 2015200
May 2015100
Jun 2015300
Jul 2015200
Aug 2015200
Sep 2015900
Oct 2015200
Nov 2015200
Dec 2015600
Jan 2016200
Feb 2016500
Mar 2016100
Apr 2016100
May 2016100
Jul 2016400
Aug 2016400
Sep 2016200
Nov 2016100
Dec 2016700
Jan 2017100
Feb 20171100
Mar 2017400
Apr 2017200
May 2017500
Jun 20171100
Jul 2017600
Aug 2017500
Sep 2017500
Oct 2017500
Nov 2017200
Dec 2017200
Jan 2018400
Feb 2018100
Mar 2018400
Apr 2018200
May 2018200
Jun 2018100
Jul 2018300
Sep 2018100
Oct 2018800
Dec 2018400
Jan 2019600
Feb 2019400
Mar 2019300
Apr 2019400
May 2019200
Jun 2019600
Jul 2019300
Aug 2019400
Sep 2019700
Oct 2019200
Dec 2019400
Jan 2020300
Feb 2020600
Mar 20201700
Apr 20201100
May 2020900
Jun 2020400
Jul 2020700
Aug 20202500
Sep 20203100
Oct 20201800
Nov 20202700
Dec 20202100
Jan 20211200
Feb 20211700
Mar 20211100
Apr 20211200
May 2021800
Jun 2021800
Jul 20212200
Aug 20213900
Sep 20211900
Oct 20211400
Nov 20217100
Dec 20214100
Jan 20228700
Feb 20222500
Mar 20221800
Apr 20221200
May 20222500
Jun 2022800
Jul 2022400
Aug 2022700
Sep 2022800
Oct 2022600
Nov 2022300
Dec 2022700
Jan 2023700
Feb 2023700
Mar 20232400
Apr 20231500
May 2023700
Jun 20231200
Jul 2023700
Aug 20231000
Sep 20231700
Oct 20231200
Nov 2023900
Dec 2023700
Jan 20241500
Feb 20241000
Mar 2024600
Apr 20241400
May 2024600
Jun 20241500
Jul 20247700
Aug 20247500
Sep 20242200
Oct 20241900
Nov 20242100
Dec 20241400
Jan 20251400
Feb 2025900
Mar 20251200
Apr 20251200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alpharadin® in the treatment of skeletal metastasis secondary to metastatic prostate cancer: An educational exhibit
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Alpharadin® in the treatment of skeletal metastasis secondary to metastatic prostate cancer: An educational exhibit
Eric Duong, Michael Orquiza, Gauri Khorjekar, Douglas Van Nostrand
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1308;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Alpharadin® in the treatment of skeletal metastasis secondary to metastatic prostate cancer: An educational exhibit
Eric Duong, Michael Orquiza, Gauri Khorjekar, Douglas Van Nostrand
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1308;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Educational Exhibits

  • Do They Work? Utilizing the "Hoshin Kanri" Process in the Nuclear Medicine Department
  • Challenges in F-18 FDG PET/CT: Benign Osseous Hypermetabolic Lesions
  • Early small bowel activity may predict rapid gastric transit on gastric emptying scintigraphy
Show more Educational Exhibits

MTA I: Educational Exhibits - Oncology

  • Pearls and pitfalls of abdominopelvic Octreotide imaging: What the radiologist and clinician need to know
  • Management and therapy of thyroid carcinoma
  • Amiodarone toxicity mimicking metastatic lung disease and liver findings: The continuing diagnostic challenge
Show more MTA I: Educational Exhibits - Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire